FELBAMATE Pharmacologic Class Indexing
- Class set ID
- 8be3a6ab-d748-4c71-b9fb-303b4b0bdcc8
- Version
- 3
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | Bryant Ranch Prepack | 20260325 | 102 |
| Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | Bryant Ranch Prepack | 20260325 | 106 |
| Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | Bryant Ranch Prepack | 20260325 | 102 |
| Felbamate Tablets, USP | Viona Pharmaceuticals Inc | Zydus Lifesciences Limited | 20260129 | 3 |
| Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | ANI Pharmaceuticals, Inc. | 20251107 | 5 |
| Before Prescribing Felbatol® (felbamate), the physician should be thoroughly familiar with the details of this prescribing information. FELBATOL® SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBATOL WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | Viatris Specialty LLC | 20250815 | 16 |
| Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | Bryant Ranch Prepack | 20250317 | 104 |
| Felbamate Tablets, USP (400 mg and 600 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited | 20241220 | 3 |
| Felbamate Oral Suspension, USP 600 mg/5 mL Rx Only | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | 20241024 | 14 |
| FELBAMATE TABLETS, USP 400 mg and 600 mg | Amneal Pharmaceuticals LLC | 20241010 | 12 |
| Felbamate Tablets, USP | Zydus Lifesciences Limited | 20240816 | 6 |
| Felbamate Tablets USP 400 mg and 600 mg | Taro Pharmaceuticals U.S.A., inc. | Taro Pharmaceutical Industries, Ltd. | 20231215 | 6 |
| Felbamate Oral Suspension, USP 600 mg/5 mL | Novitium Pharma LLC | 20220913 | 2 |
| Felbamate Oral Suspension USP | NORTHSTAR RX LLC | 20180417 | 1 |
| Felbamate Oral Suspension USP 600 mg/5 mL | Taro Pharmaceuticals U.S.A., Inc. | Taro Pharmaceutical Industries, Ltd. | 20170621 | 3 |
| FELBAMATE TABLETS | Carilion Materials Management | 20160806 | 3 |
| Felbamate Tablets | Marlex Pharmaceuticals Inc | 20150801 | 1 |